HOYA Vision Care Releases Results of First of its Kind Six-Year MiYOSMART Spectacle Lens Follow-up Clinical Study
PR95838
BANGKOK, May 6, 2022 /PRNewswire=KYODO JBN/ --
-- Strong evidence shows continued long-term lens effectiveness in slowing
myopia progression in children
HOYA Vision Care (
), a leader in optical technology innovation, shared the results of a six-year
follow-up clinical study (
) on its award winning MiYOSMART spectacle lens with Defocus Incorporated
Multiple Segments (D.I.M.S.) Technology at the Association for Research in
Vision and Ophthalmology (ARVO) 2022 conference in Denver, Colorado in the U.S.
The findings, of the longest study on a myopia management spectacle lens, were
shared by Professor Carly Lam from the Centre for Myopia Research at The Hong
Kong Polytechnic University who conducted the research.
The results of the six-year clinical tudy conducted on 90 children in Asia
looked at the progression of myopia in children who wore the HOYA Vision Care's
MiYOSMART spectacle lens. The results enhanced a previous three-year follow-up
study(1), a continuation of a two-year randomized control trial (RCT)(2), which
was published in the British Journal of Ophthalmology, demonstrating strong
evidence of the lenses' effectiveness in slowing down the progression of myopia
in children ages 8-13. The findings of the six-year, long-term follow-up study
proved the MiYOSMART spectacle lens myopia control effect is sustained over
time for children wearing the lens. It also confirmed that patients who stop
wearing the MiYOSMART spectacle lens show no rebound effects when compared to
the initial myopia rates of progression during the two-year randomized control
trial or with the general population.
"This six-year follow-up clinical study on the MiYOSMART spectacle lens, the
longest study conducted on a myopia management spectacle lens ever, shows the
myopia control effects are sustainable over time which is very exciting news,"
said Natalia Vlasak, Global head of Medical and Scientific Affairs at HOYA
Vision Care. "This study also answered another key question from eye care
professionals which was about the rebound effect of the lens - we are very
pleased that this clinical study proves that there is no rebound effect if lens
use is stopped." "HOYA Vision Care is dedicated to being a leader in developing
a safe, effective way to manage the growing problem of myopia in children," she
added.
Launched in 2018, the MiYOSMART spectacle lens was developed in cooperation
with The Hong Kong Polytechnic University to address myopia, or near
sightedness which is a growing global health concern with industry experts
predicting nearly 50% of the world's population to be impacted by 2050.(3) The
lens uses D.I.M.S. Technology that provides children with sharp vision, can be
placed in any children's eyeglass frame and appears as a standard spectacle
lens. Since 2018, one million patients in more than 30 countries have benefited
from wearing the MiYOSMART spectacle lens.(4)
(1) Lam CS, Tang WC, Lee PH, et al. Myopia control effect of defocus
incorporated multiple segments (DIMS) spectacle lens in Chinese children:
results of a 3-year follow-up study. British Journal of Ophthalmology Published
Online First: 17 March 2021. doi: 10.1136/bjophthalmol-2020-317664
(2) Lam CSY, Tang WC, Tse DY, Lee RPK, Chun RKM, Hasegawa K, Qi H, Hatanaka T,
To CH. Defocus Incorporated Multiple Segments (DIMS) spectacle lenses slow
myopia progression: a 2-year randomized clinical trial. British Journal of
Ophthalmology. Published Online First: 29 May 2019. doi:
10.1136/bjophthalmol-2018-313739
(3) Holden B.A., Fricke T.R., Wilson D.A., Jong M., Naidoo K.S., Sankaridurg
P., Wong T.Y., Naduvilath T.J., Resniko_ S. Global Prevalence of Myopia and
High Myopia and Temporal Trends from 2000 through 2050. American Academy of
Ophthalmology. 05/2016, vol.123, no. 5, p.1036–1042.
(4) Based on # lenses sold per Hoya sales data on file as of February 2022.
Individual wearer results may vary.
PRODUCT DISCLAIMER – MiYOSMART has not been approved for myopia management in
all countries, including the U.S., and is not currently available for sale in
all countries, including the U.S.
About HOYA Vision Care
For over 60 years, HOYA Vision Care has been a passionate and global leader in
optical technology innovation. As a manufacturer of high quality, high
performing eyeglass lenses, HOYA continues to drive optical technology
innovation with the aim of finding the best vision care solutions for Eye Care
Professionals. The company supplies lenses in 52 countries with a network of
over 18,000 employees and 45 laboratories around the globe.
SOURCE HOYA Vision Care
CONTACT: HOYA Vision Care PR Contact, Susan Brown, susan@wearenomads.com,
Mobile: +1 831 233 4616
本プレスリリースは発表元が入力した原稿をそのまま掲載しております。また、プレスリリースへのお問い合わせは発表元に直接お願いいたします。
このプレスリリースには、報道機関向けの情報があります。
プレス会員登録を行うと、広報担当者の連絡先や、イベント・記者会見の情報など、報道機関だけに公開する情報が閲覧できるようになります。